Cancer care in Ghana: facilities, gaps and the road ahead

Cancer care in Ghana is concentrated in a small number of major referral hospitals, while many people enter the system through a regional clinic, a district hospital or a general practitioner. Diagnosis, treatment and aftercare can save lives, yet access depends heavily on where a patient lives, what they can afford and how quickly referrals move.

At the centre of the system are Korle Bu Teaching Hospital in Accra and Komfo Anokye Teaching Hospital in Kumasi, with oncology services also offered by teaching hospitals in Cape Coast and Tamale. Public facilities work alongside private hospitals, faith-based providers and non-governmental organisations, but public centres carry much of the specialist caseload.

Patients may need imaging, pathology, surgery, chemotherapy, radiotherapy and palliative care, sometimes across several institutions. Shortages of scanners, biopsy services, trained staff and medicines can interrupt that sequence, turning a manageable referral into a prolonged and emotionally exhausting ordeal.

Australian readers will recognise the demand for timely cancer treatment, though Ghana’s health system and financing differ sharply from Medicare and Australia’s public hospital networks. Comparing the two settings offers useful lessons in referral, regional access and patient communication without pretending the systems are interchangeable.

Where treatment is available

Korle Bu is the country’s largest tertiary referral centre and hosts the National Radiotherapy Centre, where external-beam radiotherapy, brachytherapy and nuclear medicine are available. Its concentration of specialists and machines gives patients in Accra and referrals from neighbouring regions access to highly technical care.

Komfo Anokye serves Kumasi and several surrounding regions with chemotherapy, radiotherapy, surgery and diagnostic support. Oncology services at the Cape Coast and Tamale teaching hospitals have improved access in central and northern Ghana, although the range of treatments and available equipment still varies.

These centres can deliver multidisciplinary treatment, but they are not evenly distributed. A machine breakdown, delayed report or cancelled appointment has consequences when there is no nearby alternative. Some patients travel considerable distances and must meet transport, accommodation, scanning and medicine costs.

Why diagnosis often comes late

Late-stage presentation is common in several Ghanaian cancers, with breast, prostate, cervical, colorectal and liver cancers among those frequently diagnosed. The causes are not simply ignorance: symptoms may be mistaken for ordinary illness, early consultations may not produce urgent investigation, and specialist appointments can take time.

Pathology and imaging are critical gateways. A suspicious lump or lesion may require ultrasound, a biopsy, CT or MRI before an oncologist can define a treatment plan. Limited capacity and uneven laboratory quality can force repeat tests, while molecular testing remains less widely available even though it can guide treatment for some tumours.

A stronger referral culture would help. District and regional clinicians need clear routes for suspected cancer, while public education should explain that persistent swelling, unexplained bleeding, bowel changes or ongoing pain deserve assessment rather than watchful waiting.

The cost of completing treatment

The National Health Insurance Scheme covers a defined range of services, but co-payments, reimbursement gaps and out-of-stock medicines can still leave families with substantial expenses. Private insurance is limited, and patients may pay for investigations or drugs outside their coverage. Some consequently interrupt treatment, which can worsen outcomes.

Reliable power, fuel, oxygen, maintenance contracts and spare parts matter as much as the presence of a linear accelerator. Reporting on Akosombo spillage lessons demonstrates how infrastructure planning affects communities; oncology units similarly need flood protection, backup power and climate resilience to prevent avoidable treatment stoppages.

Continuity after discharge is equally important. Rehabilitation, pain control, nutrition, counselling and follow-up are easily overlooked, yet they affect whether a patient returns for review or can remain at home. Palliative care should be available alongside active treatment rather than reserved for the final days of life.

Lessons from the Australian health system

Australia’s public cancer pathway runs through Medicare and state-funded public hospitals, usually following a referral from a general practitioner. A GP can issue a prescription, colloquially called a “script”, and bulk-billed consultations are common. Private health insurance and specialist clinics provide another layer, so public and private markets operate side by side.

Major treatment networks operate in Sydney, Melbourne, Brisbane, Perth and Adelaide. People in rural or remote areas may travel further than city patients or use telehealth, with the Royal Flying Doctor Service and Flying Health Service connecting some communities to specialists. Distance is a familiar Australian issue, but Aboriginal and Torres Strait Islander communities also encounter transport barriers, historical discrimination and culturally unsafe care.

Australian public-health messaging demonstrates the value of plain language and memorable campaigns. The sun-safety expression “slip, slap, slap” is widely recognised, while breast-cancer and bowel-cancer screening messages use straightforward calls to check symptoms. Ghana can adapt the communication style, not copy the disease profile, through HPV vaccination, cervical screening, tobacco control and awareness of persistent symptoms.

A practical route through care

A practical patient checklist can make a complicated pathway easier to manage. Useful questions include which test is needed next, where results will be reviewed, how long referrals take and which expenses the National Health Insurance Scheme will cover.

• Ask for persistent symptoms to be reviewed rather than treating a lump, bleeding, bowel change or unexplained weight loss as something that will pass.
• Bring previous results, medication lists and referral letters to each appointment to reduce repeated investigations and confusion.
• Request a written treatment plan naming the hospital, responsible clinician, required tests, treatment phases and follow-up dates.
• Check insurance coverage before treatment begins and ask the regional health directorate or a cancer-support organisation about transport and financial assistance.

Relatives should record information, help patients attend appointments and speak with the clinical team when needed. A named family member or community contact can be especially valuable when treatment involves travel, prolonged hospital stays or complex medication schedules.

Building a stronger cancer network

Long-term progress requires a connected national network rather than isolated purchases of equipment. Shared protocols, reliable cancer registries, teleconsultation links, pooled maintenance expertise and transparent referral lists could reduce duplication while directing patients to the right level of care. Regional reporting can also expose gaps when clinics, scanners or medicines are unavailable.

Communities need trusted information about screening, treatment and palliative care. Local radio, hospital outreach and verified news services can counter dangerous claims about the causes of cancer, discourage unproven remedies and help families recognise legitimate specialist care without stigmatising people who seek help late.

For continuing updates on Ghana’s health services, bookmark OkayGH and follow its verified reporting. Share this guide with families navigating diagnosis, and use regional sources such as Pedro Juan News to keep pace with wider African developments.